Cyclo Therapeutics Inc logo

Cyclo Therapeutics Inc Share Price Today (NASDAQ: CYTH)

Cyclo Therapeutics Inc share price is $0 & ₹0.00 as on 24 Mar 2025 IST

▲

-0.72

(-100%)

Market is closed - opens 7 PM, 27 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 25 Mar 2025

View live Cyclo Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Cyclo Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cyclo Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Cyclo Therapeutics Inc (CYTH) Key Statistics

in dollars & INR

Previous Close
$0.7206
Open
$0.661
Market Capitalization
$23.6M
Today's Volume
$187.3K
Revenue TTM
$870.7K
EBITDA
$-24.7M
Earnings Per Share (EPS)
$-0.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-22663.91%

How to invest in Cyclo Therapeutics Inc Stock (CYTH) from India?

It is very easy for Indian residents to invest directly in Cyclo Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cyclo Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cyclo Therapeutics Inc or CYTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cyclo Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cyclo Therapeutics Inc shares which would translate to null fractional shares of Cyclo Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Cyclo Therapeutics Inc, in just a few clicks!

Global Institutional Holdings in Cyclo Therapeutics Inc

  • EPIQ Capital Group, LLC

    2.11%

  • Vanguard Group Inc

    1.83%

  • Founders Fund V Management, LLC

    1.47%

  • Geode Capital Management, LLC

    0.47%

  • Founders Fund VI Management, LLC

    0.34%

  • BlackRock Inc

    0.26%

Analyst Recommendation on Cyclo Therapeutics Inc

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Cyclo Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Cyclo Therapeutics Inc

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida. Cyclo Therapeutics, Inc. is a subsidiary of Rafael Holdings, Inc.
Organization
Cyclo Therapeutics Inc
Employees
8
CEO
Mr. N. Scott Fine
Industry
Miscellaneous

Management People of Cyclo Therapeutics Inc

NameTitle
Mr. N. Scott Fine
CEO & Director
Mr. C. E Strattan
Founder & Director
Mr. Joshua M. Fine
CFO & Secretary
Mr. Michael Eric Lisjak
Senior VP of Business Development & Chief Regulatory Officer
Dr. Jeffrey L. Tate Ph.D.
COO, Chief Quality Officer & Director
Ms. Lori McKenna
Global Head of Patient Advocacy
Dr. Karen Mullen FFPM
Interim Chief Medical Officer

Important FAQs about investing in CYTH Stock from India :

Can Indians buy Cyclo Therapeutics Inc shares?

Yes, Indians can invest in the Cyclo Therapeutics Inc (CYTH) from India.

With INDmoney, you can buy Cyclo Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cyclo Therapeutics Inc at zero transaction cost.

How can I buy Cyclo Therapeutics Inc shares from India?

It is very easy to buy Cyclo Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cyclo Therapeutics Inc (CYTH) be purchased?

Yes, you can buy fractional shares of Cyclo Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Cyclo Therapeutics Inc stocks?

To start investing in Cyclo Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Cyclo Therapeutics Inc?

Today's market capitalisation of Cyclo Therapeutics Inc CYTH is 23.6M

Who is the Chief Executive Officer (CEO) of Cyclo Therapeutics Inc ?

Mr. N. Scott Fine is the current Chief Executive Officer (CEO) of Cyclo Therapeutics Inc.